SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Epigral submits board meeting intimation

27 Apr 2026 Evaluate
Epigral has informed that pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of the Company will be held on Saturday, 2nd May, 2026, at the Registered Office of the Company, to consider, approve and take on record the following: 1. Audited Financial Results (Standalone & Consolidated) of the Company for the Fourth Quarter and Year ended 31st March, 2026 and to take on record the Report of the Statutory Auditors thereon; 2. Recommendation of Final Dividend, if any, on the Equity Shares of Rs 10 each of the Company for Financial Year ended 31st March, 2026; and 3. Any other business with the permission of the Chair.

The above information is a part of company’s filings submitted to BSE.

Epigral Share Price

1203.25 6.65 (0.56%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3640.10
Tata Chemicals 809.45
SRF 2519.20
Pidilite Inds. 1375.55
Deepak Nitrite 1736.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×